Finance

Lists
Why is BXP down 4,54%?
Dive Deeper
BXP:LON
Beximco Pharmaceuticals GDR
51,55 GBX
-4,54%
(-2,45) 1D
15 հոկ, 16:30:00 GMT+1  ·   GBX
All symbols
SymbolPriceChange% Change
Generating top insights for BXP...
Open
51,55 GBX
High
51,55 GBX
Low
51,55 GBX
Avg. vol.
21,61 հզր
Volume
172,00
52-wk high
65,00 GBX
52-wk low
36,70 GBX
Shares outstanding
405,56 մլն
No. of employees
1 հզր
Open
51,55 GBX
High
51,55 GBX
Low
51,55 GBX
Avg. vol.
21,61 հզր
Volume
172,00
52-wk high
65,00 GBX
52-wk low
36,70 GBX
Shares outstanding
405,56 մլն
No. of employees
1 հզր
News stories
From web sources and news partners
About Beximco Pharmaceuticals GDR
CEO-
Employees1,22 հզր
Founded1976
HeadquartersԴաքքա, Dhaka District, Բանգլադեշ
Sector-
Previous reportsAll values in BDT
Loading Previous Earnings...
Revenue
Net income
All values in BDT
2025 թ. հնս
2025 թ. սեպ
2025 թ. դեկ
2026 թ. մրտ
Revenue
12,50 մլրդ
13,79 մլրդ
14,01 մլրդ
13,63 մլրդ
Cost of goods sold
7,17 մլրդ
7,16 մլրդ
7,05 մլրդ
6,93 մլրդ
Cost of revenue
7,17 մլրդ
7,16 մլրդ
7,05 մլրդ
6,93 մլրդ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,10 մլրդ
3,50 մլրդ
3,84 մլրդ
3,84 մլրդ
Operating expense
3,10 մլրդ
3,50 մլրդ
3,84 մլրդ
3,84 մլրդ
Total operating expenses
10,27 մլրդ
10,66 մլրդ
10,90 մլրդ
10,77 մլրդ
Operating income
2,23 մլրդ
3,14 մլրդ
3,11 մլրդ
2,86 մլրդ
Other non operating income
113,91 մլն
129,13 մլն
203,65 մլն
193,27 մլն
EBT including unusual items
2,17 մլրդ
3,12 մլրդ
3,12 մլրդ
2,91 մլրդ
EBT excluding unusual items
2,13 մլրդ
3,12 մլրդ
3,12 մլրդ
2,91 մլրդ
Income tax expense
427,45 մլն
718,41 մլն
732,06 մլն
652,35 մլն
Effective tax rate
19,74%
23,03%
23,43%
22,44%
Other operating expenses
-
-
-
-
Net income
1,71 մլրդ
2,36 մլրդ
2,36 մլրդ
2,22 մլրդ
Net profit margin
13,67%
17,13%
16,83%
16,29%
Earnings per share
-
-
-
-
Interest and investment income
27,30 մլն
39,60 մլն
-
-
Interest expense
-161,48 մլն
-186,31 մլն
-187,24 մլն
-146,06 մլն
Net interest expenses
-134,17 մլն
-146,71 մլն
-187,24 մլն
-146,06 մլն
Depreciation and amortization charges
-
-
-
-
EBITDA
2,42 մլրդ
3,62 մլրդ
3,68 մլրդ
3,39 մլրդ
Gain or loss from assets sale
-29,40 մլն
111,00 հզր
-9,16 մլն
-4,92 մլն
AI content may include mistakes. Learn more
Google Apps